Kailera Therapeutics, Inc. 3 Filing
Ticker: KLRA · Form: 3 · Filed: Apr 16, 2026 · CIK: 0002096997
| Field | Detail |
|---|---|
| Company | Kailera Therapeutics, Inc. (KLRA) |
| Form Type | 3 |
| Filed Date | Apr 16, 2026 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 3 filing submitted by Kailera Therapeutics, Inc. (ticker: KLRA) to the SEC on Apr 16, 2026.
Where can I view the full 3 filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 16, 2026 regarding Kailera Therapeutics, Inc. (KLRA). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.